MARKET INSIGHTS
Global (S)-1-(1-Naphthyl) ethylamine (CAS 10420-89-0) market size was valued at USD 38.6 million in 2025. The market is projected to rise from USD 41.2 million in 2026 to USD 74.8 million by 2034, reflecting a CAGR of 6.9% during the forecast period.
(S)-1-(1-Naphthyl) ethylamine is a chiral amine recognized for its role as a resolving agent and chiral building block in asymmetric synthesis. Its high optical purity and naphthalene‑based structure make it a key intermediate for pharmaceuticals, agrochemicals and fine chemicals. The compound’s enantioselective properties are critical for the synthesis of optically active molecules where precise stereochemical control is required.
Demand growth is anchored by the expanding pharmaceutical industry’s need for enantiomerically pure compounds and the increasing adoption of chiral chemistry in drug development. The emphasis on green chemistry and stereoselective synthesis further reinforces the compound’s relevance across research and industrial applications. Leading suppliers such as TCI Chemicals, Sigma‑Aldrich (Merck KGaA) and Alfa Aesar maintain a significant global supply chain presence.
(S)-1-(1-Naphthyl) ethylamine (CAS 10420-89-0) Market – View in Detailed Research Report
(S)-1-(1-Naphthyl) ethylamine (CAS 10420-89-0) Market – View in Detailed Research Report
🔟 1. TCI Chemicals
Headquarters: Tokyo, Japan
Key Offering: High‑purity chiral amines for API synthesis
TCI Chemicals delivers a portfolio of pharmaceutical‑grade (S)-1-(1‑Naphthyl) ethylamine, emphasizing stringent quality control and compliance with global regulatory standards. Their production lines are designed to meet the high enantiomeric excess required for modern CNS therapeutics.
Sustainability Initiatives:
- Implementation of closed‑loop solvent recovery systems
- Adoption of renewable energy sources in manufacturing facilities
- Participation in industry‑wide green chemistry working groups
9️⃣ 2. Sigma‑Aldrich (Merck KGaA)
Headquarters: Darmstadt, Germany
Key Offering: Comprehensive catalog of chiral intermediates
As part of Merck KGaA, Sigma‑Aldrich provides a broad range of chiral building blocks, including (S)-1‑(1‑Naphthyl) ethylamine, with a focus on supporting early‑stage drug discovery and late‑stage synthesis.
Sustainability Initiatives:
- Targeted reduction of hazardous waste in the resolution process
- Investment in biocatalytic alternatives to traditional chemical resolution
- Compliance with ISO 14001 environmental management standards
8️⃣ 3. Alfa Aesar
Headquarters: Haverhill, USA
Key Offering: Laboratory‑grade chiral reagents for academic and industrial use
Alfa Aesar supplies high‑purity (S)-1‑(1‑Naphthyl) ethylamine to research institutions and small‑to‑medium enterprises, offering flexible packaging options and rapid turnaround times.
Sustainability Initiatives:
- Development of low‑solvent‑usage resolution protocols
- Collaboration with universities on green chemistry projects
- Transparent reporting of carbon footprint metrics
7️⃣ 4. Clearsynth Labs
Headquarters: Mumbai, India
Key Offering: Custom synthesis of enantiomerically pure amines
Clearsynth Labs specializes in bespoke synthesis services, leveraging proprietary asymmetric catalysis to deliver (S)-1‑(1‑Naphthyl) ethylamine with high enantiomeric excess for pharmaceutical clients.
Sustainability Initiatives:
- Use of bio‑based solvents in synthesis routes
- Implementation of waste‑to‑energy recovery systems
- Support for local capacity building in green chemistry
6️⃣ 5. Biosynth Carbosynth
Headquarters: Zurich, Switzerland
Key Offering: High‑purity chiral intermediates with GMP compliance
Biosynth Carbosynth delivers (S)-1‑(1‑Naphthyl) ethylamine to multinational pharmaceutical companies, ensuring compliance with cGMP and ISO 9001 standards.
Sustainability Initiatives:
- Optimization of catalytic cycles to reduce catalyst load
- Investment in renewable energy for plant operations
- Partnerships with NGOs to promote sustainable manufacturing
5️⃣ 6. Enamine Ltd
Headquarters: Kharkiv, Ukraine
Key Offering: Rapid synthesis of chiral amines for drug discovery
Enamine Ltd offers a streamlined synthesis platform that enables fast access to (S)-1‑(1‑Naphthyl) ethylamine, supporting academic and industrial research projects.
Sustainability Initiatives:
- Adoption of green chemistry principles in all synthesis routes
- Efficient waste minimization and recycling programs
- Engagement with local communities to promote science education
4️⃣ 7. Capot Chemical Co., Ltd.
Headquarters: Shanghai, China
Key Offering: Large‑scale production of pharmaceutical‑grade (S)-1‑(1‑Naphthyl) ethylamine
Capot Chemical combines advanced process engineering with rigorous quality assurance to supply high‑purity chiral amines to global API manufacturers.
Sustainability Initiatives:
- Implementation of energy‑efficient production lines
- Use of recyclable raw materials where feasible
- Continuous improvement of process safety and environmental impact
3️⃣ 8. Hairui (Huai’an) Chemical Technology Co., Ltd.
Headquarters: Huai’an, China
Key Offering: Custom chiral resolution services for specialty chemicals
Hairui provides tailored resolution processes for (S)-1‑(1‑Naphthyl) ethylamine, catering to niche pharmaceutical and fine‑chemical markets.
Sustainability Initiatives:
- Optimization of diastereomeric salt formation to reduce solvent use
- Adoption of green solvent alternatives in downstream processing
- Regular audits to ensure compliance with environmental regulations
2️⃣ 9. Finetech Industry Limited
Headquarters: Shenzhen, China
Key Offering: High‑purity chiral amines for API development
Finetech focuses on delivering (S)-1‑(1‑Naphthyl) ethylamine with stringent purity specifications, supporting both domestic and international pharmaceutical clients.
Sustainability Initiatives:
- Integration of renewable energy sources in manufacturing facilities
- Implementation of closed‑loop water recycling systems
- Participation in industry‑wide sustainability benchmarking programs
1️⃣ 10. Ningbo Inno Pharmchem Co., Ltd.
Headquarters: Ningbo, China
Key Offering: Cost‑effective production of enantiomerically pure amines
Ningbo Inno Pharmchem offers scalable manufacturing of (S)-1‑(1‑Naphthyl) ethylamine, emphasizing affordability without compromising quality for generic drug manufacturers.
Sustainability Initiatives:
- Use of low‑toxicity solvents in resolution steps
- Investment in process intensification to reduce energy consumption
- Transparent reporting of environmental performance metrics
Download FREE Sample Report: (S)-1-(1-Naphthyl) ethylamine (CAS 10420-89-0) Market – View in Detailed Research Report
Get Full Report Here: (S)-1-(1-Naphthyl) ethylamine (CAS 10420-89-0) Market – View in Detailed Research Report
Outlook: The Future of (S)-1-(1-Naphthyl) ethylamine Market
Looking ahead, the market is expected to continue expanding as pharmaceutical companies prioritize single‑enantiomer drugs and green chemistry initiatives. The integration of biocatalytic and asymmetric synthesis technologies is likely to improve yields and reduce environmental footprints, while regulatory alignment across regions will streamline approval pathways for new applications.
Future Trends Shaping the Market
- Adoption of biocatalytic resolution to lower costs and enhance sustainability.
- Expansion of digital platforms for real‑time supply chain transparency.
- Increased collaboration between contract manufacturers and R&D labs to accelerate chiral synthesis.
- Growth of niche agrochemical applications leveraging chiral auxiliaries.
- Regulatory focus on enantiomeric purity driving demand for high‑grade intermediates.
- Top 10 Companies in the Global Brazing Alloy Materials Market (2026): Market Leaders Shaping the Future of Metal Joining - July 15, 2026
- Top 10 Companies in the Global Glass Fiber Reinforced Plastic Composites Market (2026): Market Leaders Driving Innovation - July 15, 2026
- Top 10 Companies Driving the Polyoxalate POX Rapid Hydrolysis Controlled Release Insert Market (2026) - July 15, 2026
